Biosimilars Boosts Sandoz Q1 Sales; Backs Annual Sales Outlook
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
(RTTNews) – Sandoz Group AG (SDZNY), a Swiss company focused on generic pharmaceuticals and biosimilars, on Tuesday reported an increase in sales for the first-quarter.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1180036854-bd92321f0ee641728f625256956e8a54.jpg "Deferred Retirement Option Plans (DROPs): Everything You Need to Know")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2007594509-ba97533a0736449eb4661aa3324f7d5b.jpg "Why Should I Pay Myself First?")